Parallel
PrivateLast Round
Series A
Mar 20, 2026
Total Funding Raised
$25.35M
Company Overview
Parallel is a vertically-integrated, multi-state cannabis company that produces and sells a diverse portfolio of cannabis-based products intended to improve health and well-being. The company operates in several states, including Florida, Massachusetts, Nevada, and Texas, through its retail brands like Surterra Wellness, NETA, and The Apothecary Shoppe. Parallel's product offerings include flower, pre-rolls, vaporizer pens, tinctures, and other cannabis-infused products. The company is also involved in cannabinoid research, partnering with institutions like the University of Pittsburgh School of Medicine to advance the science of cannabis. Parallel was formally established in 2019, consolidating its various state operations and brands.
Sector
Enterprise Software
Verticals
Accounting & Expense, HR, Logistics Software
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Parallel Comps
Public and private peers based on sector, stage, and business model.
Parallel Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 20, 2026 | ||||
| Seed | Apr 3, 2025 | ||||
| Pre Seed | Aug 29, 2023 |
Parallel Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kima Ventures | Seed |
| Frazier Group | Pre Seed |
| Peak Capital | Pre Seed |
| Convoi Ventures | Pre Seed |
| Penny Jar Capital | Pre Seed |
| Hexa | Series A |
| Y Combinator | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 5, 2026
Added Ch Saintomer, a mid-market healthcare company, as a customer.
- Apr 5, 2026
Added Ch Ardeche Meridionale, a mid-market healthcare company.
Parallel Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Parallel's valuation, stock price, and market status.
